🇨🇦 OPDUALAG in Canada

OPDUALAG (RELATLIMAB-RMBW) regulatory status in Canada.

Marketing authorisation

OPDUALAG in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Canada

Frequently asked questions

Is OPDUALAG approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for OPDUALAG in Canada?

BRISTOL MYERS SQUIBB is the originator. The local marketing authorisation holder may differ — check the official source linked above.